-
Published 7/2/2026
Ko D, Evans PT, Park CM, Kato B, Van Over M, Conte MS, Cziraky M, Shah SJ, Pande AN, Hamburg NM, Rosenfield K, Menard MT, Farber A, Kim DH. Frailty and the efficacy and safety of surgical versus endovascular revascularization: post-hoc analysis of the BEST-CLI trial. Br J Surg. 2026 Jul 02; 113(7). PMID: 42227206.
-
Published 2/1/2026
Li B, Gershengorn HB, Vail EA, Wunsch H, Walkey AJ, Law AC, Ko D, Ayalon N, Kearney CM, Bosch NA. Inotrope selection in mixed cardiogenic shock with sepsis: a comparative analysis between milrinone and dobutamine. Ann Am Thorac Soc. 2026 Feb 01; 23(2):252-260. PMID: 40960311.
-
Published 1/21/2026
Palaniappan LP, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Bansal N, Currie ME, Earlie RS, Fan W, Fetterman JL, Barone Gibbs B, Heard DG, Hiremath S, Hong H, Hyacinth HI, Ibeh C, Jiang T, Johansen MC, Kazi DS, Ko D, Kwan TW, Leppert MH, Li Y, Magnani JW, Martin KA, Martin SS, Michos ED, Mussolino ME, Ogungbe O, Parikh NI, Perez MV, Perman SM, Sarraju A, Shah NS, Springer MV, St-Onge MP, Thacker EL, Tierney S, Urbut SM, Van Spall HGC, Voeks JH, Whelton SP, Wong SS, Zhao J, Khan SS. 2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2026 Mar 03; 153(9):e275-e906. PMID: 41562125.
-
Published 1/1/2026
Park CM, Thanapluetiwong S, Chen X, Oh G, Ko D, Kim DH. Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 Diabetes. Diabetes Care. 2026 Jan 01; 49(1):147-151. PMID: 41232081.
-
Published 12/29/2025
Parks AL, Lykken JM, Rieu-Werden ML, Ko D, Kim DH, Fang MC, Greenberg SM, Witt DM, Supiano MA, Shah SJ. Risk of New Indications for Anticoagulants and Thrombolytics in People With Cognitive Impairment: Implications for Anti-Amyloid Therapy. Neurology. 2026 Jan 27; 106(2):e214489. PMID: 41461060.